In the treatment of infectious diseases, nanotechnology facilitates targeted drug delivery. Nanocarriers, such as liposomes and dendrimers, can deliver drugs directly to the infected cells, reducing side effects and increasing treatment efficacy. Additionally, nanoparticles can be engineered to release drugs in a controlled manner, ensuring sustained therapeutic effects.
